Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-24-000009

Chief Financial Officer sold 2,004 shares at $20.00 ($40,080)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goeltz II Robert C. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-02 Sale : show line 1 in the form 10b5-1 −2,004 $20.00 $40,080 51,831 D
Open-market sales · 2,004 sh · avg $20.00 · $40,080
Loading xslF345X05/wk-form4_1704406978.xml…